Pre-eclampsia part 1: current understanding of its pathophysiology.
about
Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular diseasePlacental Nutrient Transport and Intrauterine Growth RestrictionAcute Atherosis of the Uterine Spiral Arteries: Clinicopathologic ImplicationsCardiovascular Complications of PregnancyA clear and present danger: inflammasomes DAMPing down disorders of pregnancyGestational weight gain and medical outcomes of pregnancyA Dormant Microbial Component in the Development of PreeclampsiaAn Integrative Analysis of Preeclampsia Based on the Construction of an Extended Composite Network Featuring Protein-Protein Physical Interactions and Transcriptional RelationshipsmiRNAs as common regulators of the transforming growth factor (TGF)-β pathway in the preeclamptic placenta and cadmium-treated trophoblasts: Links between the environment, the epigenome and preeclampsiaMalignant cancer and invasive placentation: A case for positive pleiotropy between endometrial and malignancy phenotypesComplications during pregnancy and fetal development: implications for the occurrence of chronic kidney disease.Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.DLX3 interacts with GCM1 and inhibits its transactivation-stimulating activity in a homeodomain-dependent manner in human trophoblast-derived cells.Enhanced Depth Imaging Optical Coherence Tomography: A New Way Measuring Choroidal Thickness in Pregnant Women.Gestational Diabetes Mellitus Is Associated with Altered Neutrophil ActivityThe Gene Variants of Maternal/Fetal Renin-Angiotensin System in Preeclampsia: A Hybrid Case-Parent/Mother-Control Study.Prior cesarean section is associated with increased preeclampsia risk in a subsequent pregnancy.Preeclampsia - will orphan drug status facilitate innovative biological therapies?MiR-519d-3p suppresses invasion and migration of trophoblast cells via targeting MMP-2.Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.Molecular association of pathogenetic contributors to pre-eclampsia (pre-eclampsia associome).Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromesPlacental lesions associated with acute atherosis.Annexin A1 Is Increased in the Plasma of Preeclamptic Women.Epigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-β PathwayThe Salivary Scavenger and Agglutinin (SALSA) in Healthy and Complicated PregnancyEffects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placentaInfluence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the DiseaseWhy is placentation abnormal in preeclampsia?The Pre-Eclampsia Ontology: A Disease Ontology Representing the Domain Knowledge Specific to Pre-Eclampsia.Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?Endocan of the maternal placenta tissue is increased in pre-eclampsiaThe aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signalingSevere maternal morbidity and near misses in tertiary hospitals, Kelantan, Malaysia: a cross-sectional study.Elevated Liver Enzymes in Cases of Preeclampsia and Intrauterine Growth RestrictionComparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsiaEchocardiographic Assessment of Structural and Hemodynamic Changes in Hypertension-Related PregnancyNeutrophil migration into the placenta: Good, bad or deadly?The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction.
P2860
Q26747071-877CD298-73B0-42A2-8DB0-681613D7E7FCQ26766791-3C8D196D-0826-4702-9812-C86D1973C356Q26777023-B3DAC0DE-CCF8-47BE-8A72-4C5ED37E4ADBQ26782481-337DD9CF-E39E-476F-8002-0D89EC252410Q27007734-99B67126-8D00-45FC-BF77-4C5E636FB10AQ28067095-B615B21C-EE93-47EC-A101-7F10DC4DFC2DQ28069689-2974ED55-2A93-46A1-B547-5BC5EA83F78CQ28109684-CF3072D8-2FC0-4582-8EE3-BE3401633BACQ28396485-32E58CBF-EF32-4DBB-B624-A731C67DF8A0Q28652780-0D3E3CB4-ED09-40BE-80EA-B10A31A540DBQ30235456-E4B22DF6-9FC2-4E45-AEEF-A93FC20F22F8Q33687481-31864E25-B820-447E-9DAE-E8A65F36DD03Q33700551-48A5EA25-0117-41C4-B8E0-C4EFB07878F1Q33775507-9588A088-A57D-48CD-8AE2-951463443F1CQ33794472-0CED6685-5147-4FD8-8978-FA7B0089F0EDQ33895023-8D35B2B7-F27B-49A7-AD66-A3F86FAF2DCBQ35105282-594A0FE2-8F0F-4230-BCAF-AF073441872BQ35124440-867AFA1B-F457-44A4-ABB8-4339DD292368Q35214428-5A7105B7-5E80-4F81-877E-4E118B1E89D9Q35418370-25327C12-C255-4CB2-9FCA-109F033B1F67Q35529923-CB280EBD-AAFC-41A9-89F7-B6B0E1B027EBQ35547367-AE69E4B2-2A21-4F26-8683-CD3B98FB1A0EQ35558666-9506EED4-DFDF-4C95-A6CE-7C60CEBA47E5Q35784972-620C0500-643B-42C9-92D6-954A11BD9513Q35824650-A9C953D7-6F6A-415D-ADB6-9BD1141E754DQ35909383-DE7F898A-7E15-45C2-ACAE-C3BFB0A1A854Q36024649-75F0CE1A-2DB6-4171-B02F-2D5FD0EB7F9DQ36034800-F44EBFF0-ED2F-4F65-80F1-57E7BCD32AA3Q36104833-C149E5CD-3A24-4785-B889-EE777043D996Q36119044-E86E2523-9723-47AF-A121-4A8239568DB2Q36176031-7A04B2CB-D1FF-4E90-BFC9-A5154FDF1D77Q36357099-27D4C727-E3E1-4EFF-914C-D15D0FC8F3FBQ36464599-55D212CE-B01E-4BC4-9EA2-20E509BC2B2FQ36517166-EE8E5F3B-5853-4F53-B189-3C10A8BC3699Q36654296-990DAC29-6B02-4F98-8389-0C58D704DBEAQ36654726-A78127EA-4241-48B5-B7DC-1E0E83C9D6A4Q36686732-4828651F-7284-4482-A46C-917464B8BE78Q36789043-9654AB8C-DD15-4F06-9876-601CC2F1904FQ36857949-00CCB4D8-FBA7-4E9D-B175-A17266E7F24CQ36981696-44E2C614-1D11-42CD-8548-777DCC240045
P2860
Pre-eclampsia part 1: current understanding of its pathophysiology.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pre-eclampsia part 1: current understanding of its pathophysiology.
@ast
Pre-eclampsia part 1: current understanding of its pathophysiology.
@en
type
label
Pre-eclampsia part 1: current understanding of its pathophysiology.
@ast
Pre-eclampsia part 1: current understanding of its pathophysiology.
@en
prefLabel
Pre-eclampsia part 1: current understanding of its pathophysiology.
@ast
Pre-eclampsia part 1: current understanding of its pathophysiology.
@en
P2860
P921
P356
P1476
Pre-eclampsia part 1: current understanding of its pathophysiology.
@en
P2093
Piya Chaemsaithong
P2860
P2888
P304
P356
10.1038/NRNEPH.2014.102
P407
P577
2014-07-08T00:00:00Z